Erythema migrans

From WikiMD's WELLNESSPEDIA

File:Bullseye rash linked to Lyme disease.jpg
Bullseye rash linked to Lyme disease

Erythema migrans is a distinctive skin rash typically associated with Lyme disease, a bacterial illness caused by Borrelia burgdorferi. Often referred to as a "bull's-eye" rash due to its unique appearance, erythema migrans serves as a crucial early diagnostic sign of Lyme disease.

Erythema migrans
File:Atypical erythema migrans 1 week after initial presentation.jpg
Atypical erythema migrans 1 week after initial presentation

Clinical Presentation[edit]

Erythema migrans rash usually manifests within 3 to 30 days after a tick bite, the primary vector of Borrelia burgdorferi. The rash begins at the site of the tick bite and expands over time, forming a circular or oval pattern. The center of the rash may clear as it enlarges, creating the characteristic "bull's-eye" pattern, although this is not always the case.

Diagnosis and Significance[edit]

The presence of erythema migrans in a person with potential tick exposure is highly suggestive of Lyme disease. Diagnosis is typically clinical, based on the characteristic appearance of the rash and patient history. Additional testing, such as serologic testing for Lyme disease, may be utilized if the presentation is unclear.

Treatment and Prognosis[edit]

Early treatment of Lyme disease with appropriate antibiotic therapy, such as doxycycline or amoxicillin, usually results in prompt resolution of the rash and prevents progression of the disease. Delayed or inadequate treatment may result in more serious manifestations of Lyme disease, including neurological or cardiac complications.





References[edit]

  1. "Erythema Migrans." American Osteopathic College of Dermatology (AOCD). Link
  2. Wormser GP, Dattwyler RJ, Shapiro ED, et al. (2006). "The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America." Clin Infect Dis. 43(9):1089-1134. Link
  3. Maraspin V, Lotric-Furlan S, Strle F. (2019). "Erythema migrans." In: Lyme Borreliosis. Springer, Cham. Link
  4. Steere AC, Malawista SE, Snydman DR, et al. (1977). "Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities." Arthritis Rheum. 20(1):7-17. Link

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.